Director Shareholding

GlaxoSmithKline PLC
11 July 2003

                              Directors' Interests





I give below details of changes in interests in the Ordinary Share ADRs of
GlaxoSmithKline plc (each ADR represents two Ordinary Shares) in respect of the
under-mentioned Directors arising from the reinvestment of the dividend paid to
Ordinary Share ADR holders on 3 July 2003 through the US Global BuyDirect Plan
administered by The Bank of New York:


Mr D F McHenry                      Beneficial interest in 0.274 of an Ordinary Share ADR purchased at a
                                    price of $40.875 per ADR.

Mr J H McArthur                     Beneficial interest in 33.5295 Ordinary Share ADRs purchased at a price
                                    of US$ 40.875 per ADR.




                                The Directors and the Company were advised of
                                this information on 10 July 2003.

S M Bicknell

Company Secretary

11 July 2003




                      This information is provided by RNS
            The company news service from the London Stock Exchange